We represented A.H. Harris & Sons, Incorporated in a significant recapitalization transaction, including restructuring the company’s equity and debt, with leading private equity firm, Frontenac. The transaction involved a cross-disciplinary team of attorneys practicing various aspects of business, environmental, tax and employee benefits law.
Represented Canaan Partners as a lead investor in successfully closing a $40 million Series C financing for Protagonist Therapeutics, Inc., a biotechnology company. The investment will fund continued advancement of the company’s oral peptide drugs for inflammatory bowel disease and other gastrointestinal diseases and disorders into clinical development.
In a recent ceremony held at the U.S. Department of Commerce, Shipman & Goodwin was the only law firm to receive The President’s "E" Award for Export Service. U.S. Secretary of Commerce Penny Pritzker presented the award to Ross Garber and Glenn Cunningham in recognition of the firm’s significant contributions to increasing U.S. exports. This prestigious award is the highest recognition any U.S. entity may receive for supporting export activity.